NATHALIA GAVIRIA-CORREA: Open Payments
NPI 1760953871 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,742 in 29 payments from 16 companies in 2025. Trend: 2023 $1,672 · 2024 $1,161 · 2025 $1,742
Food & beverage: $1,072Travel & lodging: $671
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 12 | $1,192 |
| ABBVIE INC. | 2 | $143 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| JAZZ PHARMACEUTICALS INC. | 1 | $33 |
| PFIZER INC. | 2 | $31 |
| Eisai Inc. | 1 | $29 |
| EMD Serono, Inc. | 1 | $28 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: Vercise, General - DBS, VRAYLAR, AUSTEDO XR, PONVORY, EPIDIOLEX, NURTEC ODT, Leqembi.
Industry payments across OR — which companies pay providers there.
